Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biological drug therapy for ocular angiogenesis: Anti‐VEGF agents and novel strategies based on nanotechnology
María Lina Formica, Hamoudi Ghassan Awde Alfonso, Santiago Daniel Palma
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases
Yue Wu, Xin Li, Xueyu Fu, et al.
Advanced Science (2024) Vol. 11, Iss. 32
Open Access | Times Cited: 26
Applications of polymeric nanoparticles in drug delivery for glioblastoma
Shuhan Liu, Bin Tan, Feng Wang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 2
Ten Years of Knowledge of Nano-Carrier Based Drug Delivery Systems in Ophthalmology: Current Evidence, Challenges, and Future Prospective
Jie Zhang, Jinghua Jiao, Meng Niu, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 6497-6530
Open Access | Times Cited: 65
Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics
Deepanjan Datta, Sony Priyanka Bandi, Viola Colaco, et al.
International Journal of Pharmaceutics (2024) Vol. 658, pp. 124192-124192
Open Access | Times Cited: 11
The role of ferroptosis in metabolic diseases
Ling Xie, Bin Fang, Chun Zhang
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 6, pp. 119480-119480
Open Access | Times Cited: 18
Systems biology of angiogenesis signaling: Computational models and omics
Yu Zhang, Hanwen Wang, Rebeca Hannah de Melo Oliveira, et al.
WIREs Mechanisms of Disease (2021) Vol. 14, Iss. 4
Open Access | Times Cited: 36
Immunotherapies targeting tumor vasculature: challenges and opportunities
Hassan Dianat‐Moghadam, Reza Nedaeinia, Mohsen Keshavarz, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Age-Related Macular Degeneration (AMD): Pathophysiology, Drug Targeting Approaches, and Recent Developments in Nanotherapeutics
Mahendra Pratap Singh, Riyakshi Negi, Alka, et al.
Medicina (2024) Vol. 60, Iss. 10, pp. 1647-1647
Open Access | Times Cited: 5
Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD)
Aira Sarkar, Vijayabhaskarreddy Junnuthula, Sathish Dyawanapelly
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10594-10594
Open Access | Times Cited: 28
Experimental and mathematical approaches for drug delivery for the treatment of wet age-related macular degeneration
Eduardo A. Chacin Ruiz, Katelyn E. Swindle‐Reilly, Ashlee N. Ford Versypt
Journal of Controlled Release (2023) Vol. 363, pp. 464-483
Open Access | Times Cited: 12
Pullulan as a sustained release carrier for ocular drug delivery: a review
Aarushi Kaith, Unnati Garg, Neha Jain, et al.
International Journal of Biological Macromolecules (2025), pp. 143146-143146
Closed Access
Application of Nanomaterials in the Diagnosis and Treatment of Retinal Diseases
Yufei Yao, Qiannan Cao, Huapan Fang, et al.
Small (2025)
Closed Access
Topical delivery of anti-VEGF macromolecules for retinopathy: A review
Varaprasad R. Regu, Ranjit Prasad Swain, Lolly Pattnaik, et al.
International Journal of Biological Macromolecules (2025), pp. 144151-144151
Closed Access
Biosimilars of ranibizumab in retinal diseases: new possibilities in ophthalmology
A. A. Voskresenskaya, М. Б. Саркизова, Н. С. Ходжаев, et al.
Russian Annals of Ophthalmology (2025) Vol. 141, Iss. 2, pp. 106-106
Closed Access
Rapamycin and Resveratrol Modulate the Gliotic and Pro-Angiogenic Response in Müller Glial Cells Under Hypoxia
Paula V. Subirada, María V. Vaglienti, Mariana Belén Joray, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 16
Role of the Immune System in Renal Transplantation, Types of Response, Technical Approaches and Current Challenges
Aitor Etxebarria, Eguzkiñe Díez-Martín, Egoitz Astigarraga, et al.
Immuno (2022) Vol. 2, Iss. 4, pp. 548-570
Open Access | Times Cited: 12
Design, Synthesis and Cytotoxicity Screening of New Thiazole Derivatives as Potential Anticancer Agents through VEGFR-2 Inhibition
Tarfah Al‐Warhi, Matokah M. Abualnaja, Ola A. Abu Ali, et al.
Symmetry (2022) Vol. 14, Iss. 9, pp. 1814-1814
Open Access | Times Cited: 11
The Therapeutic Benefits of Nanoencapsulation in Drug Delivery to the Anterior Segment of the Eye: A Systematic Review
Madhavi Bhandari, Sanko Nguyen, Mazyar Yazdani, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling
Anastasia Chillà, Cecilia Anceschi, Elena Frediani, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
An Update on Strategies to Deliver Protein and Peptide Drugs to the Eye
Sai H. S. Boddu, Devarshi Acharya, Vivek Hala, et al.
ACS Omega (2023) Vol. 8, Iss. 39, pp. 35470-35498
Open Access | Times Cited: 4
Nanotechnological approaches to improve corticosteroids ocular therapy
María Lina Formica, Juan Matías Pernochi Scerbo, Hamoudi Ghassan Awde Alfonso, et al.
Methods (2024)
Closed Access | Times Cited: 1
Incorporation of immunotherapies and nanomedicine to better normalize angiogenesis-based cancer treatment
Saade Abdalkareem Jasim, I.M. Farber, Sara Abdalrazzaq M. Noraldeen, et al.
Microvascular Research (2024) Vol. 154, pp. 104691-104691
Closed Access | Times Cited: 1
Niosome-encapsulated auraptene reduced the mRNA expression of VEGF-A and PDGFs genes in human retina-derived RPE cell line
Akram Vahidi, Farzad Dastaviz, Mehdi Sheikh Arabi, et al.
International Journal of Ophthalmology (2024) Vol. 17, Iss. 6, pp. 1028-1035
Open Access | Times Cited: 1
The protein biosynthesis inhibitor vioprolide A evokes anti-angiogenic and pro-survival actions by targeting NOP14 and decreasing VEGF receptor 2- and TAZ-signaling
Luisa D. Burgers, Yanfen Li, Stylianos Michalakis, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113174-113174
Open Access | Times Cited: 6
Novel therapies for proliferative retinopathies
Juan Manuel Martínez-Alejo, Leopoldo Martín Baiza-Durán, Juan D Quintana-Hau
Therapeutic Advances in Chronic Disease (2022) Vol. 13
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top